Sosei Group (4565) Price & Analysis

Compare

1 Followers

4565 Stock Chart & Stats

Day’s Range― - ―

52-Week Range¥668.00 - ¥1,754.00

Previous CloseN/A

Volume458.60K

Average Volume (3M)714.07K

Market Cap

$73.93B

Enterprise ValueN/A

Total Cash (Recent Filing)$36.20B

Total Debt (Recent Filing)¥67.90B

Price to Earnings (P/E)―

Beta0.88

Next Earnings

Aug 07, 2025

EPS Estimate

17.83

Last Dividend Ex-Date

Mar 27, 2015

Dividend YieldN/A

Share Statistics

EPS (TTM)-8.45

Shares Outstanding90,384,090

10 Day Avg. Volume591,370

30 Day Avg. Volume714,070

Financial Highlights & Ratios

PEG Ratio0.55

Price to Book (P/B)1.18

Price to Sales (P/S)0.00

P/FCF Ratio-9.80

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$1,849.74

Price Target Upside126.41% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Sosei Group News

PremiumCompany Announcements

Nxera Pharma Reports Revenue Growth Amidst Losses

26d ago

PremiumCompany Announcements

Nxera Pharma Reports Strong Q1 2025 Results and Strategic Advances

27d ago

PremiumCompany Announcements

Nxera Pharma’s Schizophrenia Treatment Enters Phase 3 Trials

28d ago

PremiumPre-Earnings

Sosei Group Corporation (SOLTF) Q1 Earnings Cheat Sheet

29d ago

PremiumCompany Announcements

Nxera Pharma’s Partner Advances Phase 2 Trial for Alcohol Use Disorder Treatment

2M ago

PremiumCompany Announcements

Nxera Pharma Assigns Cenerimod Rights to Viatris for Japan and APAC

3M ago

PremiumCompany Announcements

Nxera Pharma Corrects Financial Notice on Capital Reserve and Surplus Disposition

3M ago

PremiumCompany Announcements

Nxera Pharma Plans Capital Reserve Reduction for Shareholder Flexibility

3M ago

See All JP:4565 News

See All News >

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

3.17%

Mutual Funds

― Other Institutional Investors

93.43% Public Companies and

Individual Investors

Detailed Ownership Overview >

4565 FAQ

What was Sosei Group Corporation’s price range in the past 12 months?

Sosei Group Corporation lowest stock price was ¥668.00 and its highest was ¥1754.00 in the past 12 months.

What is Sosei Group Corporation’s market cap?

Sosei Group Corporation’s market cap is $73.93B.

When is Sosei Group Corporation’s upcoming earnings report date?

Sosei Group Corporation’s upcoming earnings report date is Aug 07, 2025 which is in 70 days.

How were Sosei Group Corporation’s earnings last quarter?

Sosei Group Corporation released its earnings results on May 02, 2025. The company reported -¥8.45 earnings per share for the quarter, beating the consensus estimate of -¥40.119 by ¥31.669.

Is Sosei Group Corporation overvalued?

According to Wall Street analysts Sosei Group Corporation’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Sosei Group Corporation pay dividends?

Sosei Group Corporation pays a Notavailable dividend of ¥2.499 which represents an annual dividend yield of N/A. See more information on Sosei Group Corporation dividends here

What is Sosei Group Corporation’s EPS estimate?

Sosei Group Corporation’s EPS estimate is 17.83.

How many shares outstanding does Sosei Group Corporation have?

Sosei Group Corporation has 90,384,090 shares outstanding.

What happened to Sosei Group Corporation’s price movement after its last earnings report?

Sosei Group Corporation reported an EPS of -¥8.45 in its last earnings report, beating expectations of -¥40.119. Following the earnings report the stock price went up 1.965%.

Which hedge fund is a major shareholder of Sosei Group Corporation?

Currently, no hedge funds are holding shares in JP:4565

Company Description

Sosei Group Corporation

Sosei Group Corporation, a prominent biopharmaceutical company based in Japan, specializes in the development and commercialization of innovative medicines. The company operates primarily in the biotechnology and pharmaceutical sectors, focusing on drug discovery and early-stage clinical development. Sosei Group leverages its proprietary drug discovery platform to create novel therapeutics, with a particular emphasis on addressing unmet medical needs in disease areas such as neurology, immunology, and oncology.

4565 Company Deck

4565 Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call highlighted significant revenue growth and strategic partnerships, contributing to an improved core operating profit. However, concerns remain regarding operating losses and increasing expenses, which could affect future financial performance.Read More>

4565 Stock 12 Month Forecast

Average Price Target

¥1,849.74

▲(126.41%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"847":"¥847","2000":"¥2,000","1135.25":"¥1,135.3","1423.5":"¥1,423.5","1711.75":"¥1,711.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1999.99999994984,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥2.00K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1849.74388157,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥1.85K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1699.999999957364,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥1.70K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[847,1135.25,1423.5,1711.75,2000],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2020","6":"Nov<br/>2020","9":"Mar<br/>2021","12":"Mar<br/>2025","25":"Mar<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,848,936.6153846115261,1025.2307692230522,1113.8461538345784,1202.4615384461047,1291.0769230576307,1379.692307669157,1468.307692280683,1556.9230768922093,1645.5384615037353,1734.1538461152616,1822.7692307267876,1911.3846153383138,{"y":1999.99999994984,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,848,925.0572216592308,1002.1144433184616,1079.1716649776922,1156.228886636923,1233.2861082961538,1310.3433299553844,1387.4005516146153,1464.4577732738462,1541.5149949330769,1618.5722165923075,1695.6294382515384,1772.686659910769,{"y":1849.74388157,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,848,913.5384615351818,979.0769230703637,1044.6153846055456,1110.1538461407274,1175.6923076759092,1241.2307692110912,1306.769230746273,1372.3076922814548,1437.8461538166366,1503.3846153518184,1568.9230768870004,1634.4615384221822,{"y":1699.999999957364,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1966,"date":1588291200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1966,"date":1590969600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1966,"date":1593561600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1966,"date":1596240000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1966,"date":1598918400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1966,"date":1601510400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1966,"date":1604188800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1966,"date":1606780800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1966,"date":1606780800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1855,"date":1614556800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1663,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1226,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":848,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >